Korean Biopharma Today And Tomorrow: M&A, Investment, Governance

Policies, Family Management In Spotlight

 
• By Jung Won Shin
  
Korea Bioplus Interphex
M&A The Biggest Keyword For Korean Biopharmas In Next Decade • Source: Jung Won Shin
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia